Figure 5
Analysis of APL arising from mCG-PR2VR mice. (A) Analysis of leukemic mCG-PRWT (n = 11) and mCG-PR2VR (n = 29) mice for spleen weights, complete blood counts, and immunophenotyping by flow cytometry for Gr-1+/CD117+ blasts. (B) Immunophenotyping and (C) Wright-Giemsa staining of spleen cells from representative leukemic mCG-PRWT and mCG-PR2VR mice. (D-E) Western blotting of cell lysates from (D) bone marrow of preleukemic mice (E) spleen from leukemic mice. * represents a nonspecific band observed in the bone marrow extracts. Controls are a U937-PR9 cell line that contains the PR cDNA under the control of a Zinc (Zn2+) inducible promoter treated with 100μM ZnSO4 for 1 hour.

Analysis of APL arising from mCG-PR2VR mice. (A) Analysis of leukemic mCG-PRWT (n = 11) and mCG-PR2VR (n = 29) mice for spleen weights, complete blood counts, and immunophenotyping by flow cytometry for Gr-1+/CD117+ blasts. (B) Immunophenotyping and (C) Wright-Giemsa staining of spleen cells from representative leukemic mCG-PRWT and mCG-PR2VR mice. (D-E) Western blotting of cell lysates from (D) bone marrow of preleukemic mice (E) spleen from leukemic mice. * represents a nonspecific band observed in the bone marrow extracts. Controls are a U937-PR9 cell line that contains the PR cDNA under the control of a Zinc (Zn2+) inducible promoter treated with 100μM ZnSO4 for 1 hour.

Close Modal

or Create an Account

Close Modal
Close Modal